Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Invested Capital (2020 - 2025)

LifeStance Health (LFST) has disclosed Invested Capital for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital rose 5.17% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 5.17% increase, with the full-year FY2025 number at $1.5 billion, up 5.17% from a year prior.
  • Invested Capital was $1.5 billion for Q4 2025 at LifeStance Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.6 billion in Q4 2021 to a low of $954.0 million in Q1 2021.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 63.1% in 2022, then dropped 6.35% in 2023.
  • LifeStance Health's Invested Capital stood at $1.6 billion in 2021, then fell by 1.57% to $1.5 billion in 2022, then dropped by 6.35% to $1.4 billion in 2023, then grew by 0.64% to $1.4 billion in 2024, then grew by 5.17% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LFST's Invested Capital are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).